Publication

The international donor community has succeeded in supporting a vast expansion of access to subsidized AIDS treatment. The AIDS treatment entitlement engenders dependency among its beneficiaries and restricts the flexibility of the donors and governments that assume its burden. This essay presents original estimates of the magnitude of the future fiscal burden of AIDS treatment under alternative assumptions and then proposes policy options to harmonize the incentives to sustain treatment quality while leveraging treatment demand for the prevention of future cases.